AU541056B2 - Pharmaceuticals formulations - Google Patents

Pharmaceuticals formulations

Info

Publication number
AU541056B2
AU541056B2 AU68166/81A AU6816681A AU541056B2 AU 541056 B2 AU541056 B2 AU 541056B2 AU 68166/81 A AU68166/81 A AU 68166/81A AU 6816681 A AU6816681 A AU 6816681A AU 541056 B2 AU541056 B2 AU 541056B2
Authority
AU
Australia
Prior art keywords
pharmaceuticals formulations
pharmaceuticals
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU68166/81A
Other languages
English (en)
Other versions
AU6816681A (en
Inventor
Alphonse Peter Granatek
Murray Arthur Kaplan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU6816681A publication Critical patent/AU6816681A/en
Application granted granted Critical
Publication of AU541056B2 publication Critical patent/AU541056B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU68166/81A 1980-03-31 1981-03-06 Pharmaceuticals formulations Ceased AU541056B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US135373 1980-03-31

Publications (2)

Publication Number Publication Date
AU6816681A AU6816681A (en) 1981-10-08
AU541056B2 true AU541056B2 (en) 1984-12-13

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68166/81A Ceased AU541056B2 (en) 1980-03-31 1981-03-06 Pharmaceuticals formulations

Country Status (30)

Country Link
JP (1) JPS56152415A (cs)
KR (1) KR860000841B1 (cs)
AR (1) AR225500A1 (cs)
AT (1) AT370996B (cs)
AU (1) AU541056B2 (cs)
BE (1) BE888209A (cs)
CA (1) CA1162479A (cs)
CH (1) CH647481A5 (cs)
CS (1) CS246051B2 (cs)
DD (1) DD157762A5 (cs)
DE (1) DE3112272A1 (cs)
DK (1) DK158564C (cs)
ES (1) ES500869A0 (cs)
FI (1) FI70670C (cs)
FR (1) FR2480605A1 (cs)
GB (1) GB2074028B (cs)
GR (1) GR72769B (cs)
HU (1) HU183379B (cs)
IE (1) IE51070B1 (cs)
IL (1) IL62517A (cs)
IT (1) IT1170838B (cs)
LU (1) LU83270A1 (cs)
NL (1) NL8101531A (cs)
NO (1) NO156675C (cs)
NZ (1) NZ196519A (cs)
PH (1) PH17152A (cs)
PT (1) PT72774B (cs)
SE (1) SE455045B (cs)
SU (1) SU1056893A3 (cs)
ZA (1) ZA812084B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DK0929293T3 (da) * 1996-08-23 2004-02-02 Sequus Pharm Inc Liposomer indeholdende en cisplatinforbindelse
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US11752135B2 (en) 2018-03-29 2023-09-12 Project Pharmaceutics Gmbh Liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin

Also Published As

Publication number Publication date
FR2480605A1 (fr) 1981-10-23
GB2074028B (en) 1983-09-21
GR72769B (cs) 1983-12-02
NZ196519A (en) 1983-06-17
DK158564B (da) 1990-06-11
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
FI810934L (fi) 1981-10-01
IE51070B1 (en) 1986-09-17
NO156675C (no) 1987-11-04
GB2074028A (en) 1981-10-28
JPS6360008B2 (cs) 1988-11-22
AR225500A1 (es) 1982-03-31
HU183379B (en) 1984-04-28
CA1162479A (en) 1984-02-21
ES8206545A1 (es) 1982-08-16
LU83270A1 (fr) 1981-10-29
IT8148090A0 (it) 1981-03-24
NO156675B (no) 1987-07-27
IE810715L (en) 1981-09-30
DE3112272A1 (de) 1982-04-29
DK158564C (da) 1990-11-05
FI70670B (fi) 1986-06-26
FR2480605B1 (cs) 1984-05-11
KR830004849A (ko) 1983-07-20
NO811081L (no) 1981-10-01
ATA150481A (de) 1982-10-15
DK144281A (da) 1981-10-01
PT72774B (en) 1982-11-16
SE455045B (sv) 1988-06-20
PH17152A (en) 1984-06-13
IL62517A (en) 1984-01-31
AU6816681A (en) 1981-10-08
IL62517A0 (en) 1981-05-20
SU1056893A3 (ru) 1983-11-23
JPS56152415A (en) 1981-11-26
BE888209A (fr) 1981-09-30
PT72774A (en) 1981-04-01
DE3112272C2 (cs) 1990-09-27
DD157762A5 (de) 1982-12-08
ES500869A0 (es) 1982-08-16
KR860000841B1 (ko) 1986-07-09
ZA812084B (en) 1982-04-28
FI70670C (fi) 1986-10-06
NL8101531A (nl) 1981-10-16
IT1170838B (it) 1987-06-03
SE8101990L (sv) 1981-11-13
CS246051B2 (en) 1986-10-16

Similar Documents

Publication Publication Date Title
AU557152B2 (en) Solid-pigment formulations
AU545437B2 (en) 2-amino-6-trifluoromethoxy-benzothiazole medicament
AU544099B2 (en) Triazolylpentenols
AU537992B2 (en) Polusilanes
AU542600B2 (en) Platinum-diamines
AU545667B2 (en) Diamino-pyridines
AU538782B2 (en) Triazoloquinoxalin-4-ones
AU536754B2 (en) Imidodisulfamides
AU539188B2 (en) Skin-packaging
AU3206284A (en) 2-guanidno-4-heteroarylthiazoles
AU542824B2 (en) Sustained release pharmaceuticals
AU546022B2 (en) Combi-equipment
AU545397B2 (en) Cloches
AU541912B2 (en) 2-nitroimidazoles
AU537824B2 (en) Oxygensensor
AU541056B2 (en) Pharmaceuticals formulations
AU540787B2 (en) 4-indenyl-alkyl-piperidenes
AU527275B2 (en) Auto-diaphragm hemodialyser
AU558670B2 (en) Pharmaceutical compositions
AU543520B2 (en) Kijanimicin
AU537073B2 (en) Haloacetanilide
AU534814B2 (en) Showstand
AU541732B2 (en) 11a-amino-androstanes
AU517843B2 (en) Guanylamidines
AU538427B2 (en) Dichlorobenzoyl-3-phenylpyrazolines